MM
Vice President, Quality
Get the full picture
Sign in to uncover key details.
Impel Pharmaceuticals
Manufacturing · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
201 Elliott Ave W Ste 260, Seattle, Wash...Phone Number
(206) 568-1466Website
www.impelpharma.comRevenue
$21 MillionStock Symbol
IMPLIndustry
About Impel Pharmaceuticals
Impel Pharmaceuticals specializes in developing innovative therapies using its proprietary Precision Olfactory Delivery (POD) technology for conditions such as Alzheimer's and migraines. The company focuses on creating transformative intranasal drug treatments for diseases with high unmet medical needs, exemplified by its approved migraine treatment, Trudhesa. Impel Pharmaceuticals aims to enhance drug delivery through optimized absorption in the upper nasal space. The company is also exploring partnerships and collaborations to expand the therapeutic potential of its technology.Explore more
Impel Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Impel Pharmaceuticals
Compare insights from companies similar to Impel Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Impel Pharmaceuticals
$21M
51-200
Public
$346.6M
2008
EG
Ellen GettenbergSenior VP, Commercial Operations
Impel Pharmaceuticals Tech Stack
A closer look at the technologies used by Impel Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Impel Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Impel Pharmaceuticals specializes in developing innovative therapies using its proprietary Precision Olfactory Delivery (POD) technology for conditions such as Alzheimer's and migraines. The company focuses on creating transformative intranasal drug treatments for diseases with high unmet medical needs, exemplified by its approved migraine treatmen... Read More
